» Articles » PMID: 26859151

Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer

Overview
Journal PLoS One
Date 2016 Feb 10
PMID 26859151
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Dual-specificity phosphatases (DUSPs) dephosphorylate threonine/serine and tyrosine residues on their substrates. Here we show that DUSP1, DUSP4, and DUSP6 are involved in epithelial-to-mesenchymal transition (EMT) and breast cancer stem cell (CSC) regulation. DUSP1, DUSP4, and DUSP6 are induced during EMT in a PKC pathway signal-mediated EMT model. We show for the first time that the key chromatin-associated kinase PKC-θ directly regulates a subset of DUSP family members. DUSP1, DUSP4, and DUSP6 globally but differentially co-exist with enhancer and permissive active histone post-translational modifications, suggesting that they play distinct roles in gene regulation in EMT/CSCs. We show that nuclear DUSP4 associates with the key acetyltransferase p300 in the context of the chromatin template and dynamically regulates the interplay between two key phosphorylation marks: the 1834 (active) and 89 (inhibitory) residues central to p300's acetyltransferase activity. Furthermore, knockdown with small-interfering RNAs (siRNAs) shows that DUSP4 is required for maintaining H3K27ac, a mark mediated by p300. DUSP1, DUSP4, and DUSP6 knockdown with siRNAs shows that they participate in the formation of CD44hi/CD24lo/EpCAM+ breast CSCs: DUSP1 knockdown reduces CSC formation, while DUSP4 and DUSP6 knockdown enhance CSC formation. Moreover, DUSP6 is overexpressed in patient-derived HER2+ breast carcinomas compared to benign mammary tissue. Taken together, these findings illustrate novel pleiotropic roles for DUSP family members in EMT and CSC regulation in breast cancer.

Citing Articles

Coordinated inflammation and immune response transcriptional regulation in breast cancer molecular subtypes.

Velazquez-Caldelas T, Zamora-Fuentes J, Hernandez-Lemus E Front Immunol. 2024; 15:1357726.

PMID: 38983850 PMC: 11231215. DOI: 10.3389/fimmu.2024.1357726.


miR-147b mediated suppression of DUSP8 promotes lung cancer progression.

Turkowski K, Herzberg F, Gunther S, Weigert A, Haselbauer T, Fink L Oncogene. 2024; 43(16):1178-1189.

PMID: 38396293 PMC: 11014796. DOI: 10.1038/s41388-024-02969-7.


DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling Pathway.

Al-Mutairi M, Habashy H Molecules. 2022; 27(19).

PMID: 36234680 PMC: 9572343. DOI: 10.3390/molecules27196146.


Silencing circFTO inhibits malignant phenotype through modulating DUSP4 expression in clear cell renal cell carcinoma.

Yang C, Zang Y, Wu S, Zhou Q, Ou Y, Ding Q Cell Death Discov. 2022; 8(1):392.

PMID: 36127345 PMC: 9489864. DOI: 10.1038/s41420-022-01138-7.


Upregulation of dual-specificity phosphatase-26 is required for transforming growth factor β1(TGFβ1)-induced Epithelial-mesenchymal transition in A549 and PANC1 cells.

Guler S, Zik B, Yalcin A Mol Biol Rep. 2022; 49(11):10195-10204.

PMID: 36053282 DOI: 10.1007/s11033-022-07893-1.


References
1.
De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013; 13(2):97-110. DOI: 10.1038/nrc3447. View

2.
Keyse S . Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008; 27(2):253-61. DOI: 10.1007/s10555-008-9123-1. View

3.
Avraham A, Jung S, Samuels Y, Seger R, Ben-Neriah Y . Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes. Eur J Immunol. 1998; 28(8):2320-30. DOI: 10.1002/(SICI)1521-4141(199808)28:08<2320::AID-IMMU2320>3.0.CO;2-K. View

4.
Lazo J, Nemoto K, Pestell K, Cooley K, Southwick E, Mitchell D . Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol Pharmacol. 2002; 61(4):720-8. DOI: 10.1124/mol.61.4.720. View

5.
Sutcliffe E, Bunting K, He Y, Li J, Phetsouphanh C, Seddiki N . Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol Cell. 2011; 41(6):704-19. DOI: 10.1016/j.molcel.2011.02.030. View